Gati Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.85 Cr
About Gati Diagnostic
Gati Diagnostic Private Limited (GDPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2021 (Three years and ten months 14 days old ). Its registered office is in Sikar, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹12.85 Cr.
Shishupal Khedar, Sanjeev Rahar, and Mahipal Choudhary serve as directors at the Company.
Company Details
-
Location
Sikar, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300RJ2021PTC074256
-
Company No.
074256
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Mar 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Gati Diagnostic?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shishupal Khedar
|
Director | 28-Jun-2021 | Current |
|
Sanjeev Rahar
|
Director | 24-Mar-2021 | Current |
|
Mahipal Choudhary
|
Director | 24-Mar-2021 | Current |
Financial Performance of Gati Diagnostic.
Enhance accessibility to Gati Diagnostic's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gati Diagnostic?
Unlock access to Gati Diagnostic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Centre For Sight I Max Eye Care Private LimitedSanjeev Rahar is a mutual person
Charges (Loans)
₹12.85 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.85 Cr
- Others : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2022 | Others | ₹3.00 Cr | Open |
| 10 Sep 2021 | State Bank Of India | ₹9.85 Cr | Open |
How Many Employees Work at Gati Diagnostic?
Gati Diagnostic has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gati Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gati Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.